Alimera Sciences (STU:ASZ1) Interest Expense : €-11.30 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Alimera Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Alimera Sciences's interest expense for the three months ended in Mar. 2024 was € -3.44 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-11.30 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Alimera Sciences's Operating Income for the three months ended in Mar. 2024 was € -2.12 Mil. Alimera Sciences's Interest Expense for the three months ended in Mar. 2024 was € -3.44 Mil. Alimera Sciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alimera Sciences Interest Expense Historical Data

The historical data trend for Alimera Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alimera Sciences Interest Expense Chart

Alimera Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-4.38

-4.42

-4.79

-5.55

-9.34

Alimera Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-1.56	-1.56	-1.94	-4.36	-3.44

Alimera Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-11.30 Mil.

Alimera Sciences (STU:ASZ1) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alimera Sciences's Interest Expense for the three months ended in Mar. 2024 was €-3.44 Mil. Its Operating Income for the three months ended in Mar. 2024 was €-2.12 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €63.88 Mil.

Alimera Sciences's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Alimera Sciences did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Alimera Sciences (STU:ASZ1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alimera Sciences Inc (STU:ASZ1) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ALIM:USA ASZ1:Germany

Address

6310 Town Square, Suite 400, Alpharetta, GA, USA, 30005

Website

https://www.alimerasciences.com

Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a leading cause of blindness, and outside the U.S. for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients to maintain vision longer, and importantly, with fewer injections. The company commercializes ILUVIEN in the U.S., Europe, China and the Middle East.

Alimera Sciences (STU:ASZ1) Headlines

No Headlines